OptimizeRx Corp Insider Transaction

Edward Stelmakh, Chief Finance & Strat Officer at OptimizeRx Corp, reported a disposition of 3,658 common shares on December 23, 2025. The shares were withheld by the issuer to cover tax obligations upon the vesting of restricted stock units. The transaction price was $12.74 per share, and Mr. Stelmakh now owns 123,172 shares. This transaction is treated as a disposition under Section 16 of the Securities Exchange Act.